Immunotherapy and Emergency Medicine

On this episode of CANCER BUZZ, learn why a trip to the emergency department is different for patients who receive immunotherapy for cancer, what information helps ED clinicians, and what busy emergency departments providers need to know about immune-related adverse events in patients treated with checkpoint inhibitors.

Guest:

Sarah Dubbs, MD, Assistant Professor in Emergency Medicine; Assistant Director of the Emergency Medicine Residency Program, University of Maryland School of Medicine

Relevant Content:

IO Wallet Card, by the ACCC Immuno-Oncology Institute “IO Patients in the Emergency Department,” by Junaid Razzak, MBBS, MD, PhD “Communication: Key to Addressing Toxicity and Recurrence Risks,” by Mark B. Faries, MD “Immunotherapy Complications in the Emergency Department,” by Adarsh Srivastava, MD, American Academy of Emergency Medicine “Management of Immune Checkpoint Inhibitor Toxicities: A Review and Clinical Guideline for Emergency Physicians,” by Adam T. Hryniewicki et al. “Pseudoprogression in Patients Treated with Immunotherapy,” by Ryan M. Weight, DO, MS

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.